Venezuela likely to get IMF loan support after necessary groundwork, Georgieva says

Venezuela is likely to receive IMF loan support after completing necessary groundwork, according to IMF Managing Director Kristalina Georgieva. The aid aims to stabilize Venezuela's economy amid ongoing financial reforms and efforts to restore international financial relations.

More Finance

Finance

Rosner on Credit Markets Amid Geopolitical Tension

Lindsay Rosner of Goldman Sachs discussed credit markets amid geopolitical tensions, noting that despite tight spreads, yields remain attractive. She emphasized the resilience of private credit and the importance of yield opportunities in current market conditions, speaking on Bloomberg's 'Real Yield'.

Bloomberg Markets·1h ago

Finance

Live Nation Inks $742 Million of Private Debt Tied to Venues

Live Nation has secured approximately €630 million ($742 million) in private debt to finance its global expansion of concert venues. The borrowing aims to support ongoing investments in live entertainment infrastructure, reflecting strong investor confidence in the company's growth prospects.

Bloomberg Markets·2h ago

Finance

IMF, World Bank Navigate Economic Fallout From Iran War

IMF and World Bank officials expressed concern over the global economic outlook amid ongoing fallout from the Iran war, highlighting risks of a new crisis during this week’s meetings. Discussions focused on the potential for increased instability and the need for coordinated responses.

Bloomberg Markets·2h ago

Finance

Fed’s Waller says rate cuts still possible this year if war ends quickly

Fed’s Waller indicated that rate cuts could occur later this year if the Ukraine conflict ends quickly. He emphasized that inflation remains a concern, but a resolution to the war could prompt monetary easing, supporting economic growth and market stability.

Investing.com·2h ago

Finance

Biotech Odyssey, Medical Device Firm Mobia File for US IPOs

Biotech and medical device firms, including Mobia, are preparing for US IPOs amid strong investor demand for biotech stocks. Several healthcare companies are seeking public listings to capitalize on the robust market environment, signaling continued growth in the sector.

Bloomberg Markets·2h ago

Finance

Autoimmune, Inflammatory-Focused Biotech Odyssey Files for IPO

Odyssey Therapeutics filed for a US IPO, joining a surge of biotech companies seeking public listings. The firm focuses on autoimmune and inflammatory diseases, amid strong investor demand for biotech stocks.

Bloomberg Markets·2h ago

All Finance →